• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay Kits
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • MAPK8 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • PKR Assay Kits
      • TBK1 Assay Kits
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • ADK Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • MAPK8 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • PKR Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Ubiquitin Ligase Assay: A Handy Tool for Drug Discovery

by Bellbrook Labs / Wednesday, 29 May 2019 / Published in Emerging Targets, HTS Assays
Ubiquitin Ligase Assay Tool for Drug Discovery

Can one cellular pathway contribute to many different types of disease? Research has shown that Ubiquitination is one such pathway due to its role in the regulation of protein degradation within homeostasis, cell cycle, and DNA repair. It has been established that at least the following diseases are among those affected from alterations in this pathway: cancer, viral infection and neurodegenerative disorders to muscle wasting, diabetes, and inflammation.1  Obviously, targeting the aberrations that lead to disease in this protein turnover pathway could benefit individuals tremendously. Scientists are making it their mission to find ways to inhibit the damage caused by unnecessary ubiquitination.

 

The Role of Ubiquitin Ligase in Ubiquitination

Destroying proteins doesn’t always lead to diseases. Consider the immune response. Ubiquitination is a way to clear unwanted foreign proteins from our body. Whether done for good or to cause harm, the pathway is the same. This rather complex system consists of multiple enzymatic reactions in order to allow the ubiquitin protein access to the target protein (the protein that will get degraded). Think of it as a chain of individual reactions leading to the destruction of a protein. Initially, the ubiquitin-activating enzyme (E1) activates ubiquitin via an ATP-dependent reaction.2 Once activated, ubiquitin is transferred to the ubiquitin-conjugating enzyme (E2), forming another intermediate, which is able to bind to the final ubiquitin-protein ligase (E3).2 Finally, the ligase transfers the activated ubiquitin from E2 to the side chain of a lysine residue of the target protein.2 Though this is a simplified version, it shows the multiple steps and molecules involved in order to obliterate a single protein.

Ubiquitin Cycle and Protein Degradation

How A Ubiquitin Ligase Assay Can Help

There are numerous ubiquitin ligases that regulate important cellular functions such as the case with MDM2, which regulates the tumor suppressor p53 gene.1 If the balance gets offset and MDM2 catalyzes the p53 protein, tumor progression is likely to occur. There are many other examples like this in which proteins responsible for proper cellular function get destroyed leading to disease. Fortunately, scientists have found a way to exploit the natural ubiquitination enzymatic reaction in order to investigate drug targets, ubiquitin ligase inhibitors.

Ubiquitin Ligase Cascade

BellBrook Labs has developed a novel assay platform called Transcreener® HTS Assay that detects the production of AMP using fluorescent immunodetection; AMP is produced in the complex ubiquitination pathway since ATP is one of the substrates.3 The assay relies on antibodies that differentiate between nucleotides on the basis of small structural differences, such as a single phosphate group.3 Therefore, it can be used as a ubiquitin ligase assay with the ability to monitor enzymatic activity of ubiquitin ligases and the effects of its inhibitor.

References

  1. Petroski MD. The ubiquitin system, disease, and drug discovery. 2008;15:1-15. doi:10.1186/1471-2091-9-S1-S7.
  2. Jain J, Jain SK, Walker LA, Tekwani BL. Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads. 2017:1-10. doi:10.1186/s40360-017-0147-4.
  3. Staeben M, Klink TA, Kopp A, Westermeyer TA, Kleman-leyer KM. Interrogation of Protein Phosphorylation , Ubiquitination , and Sumoylation Pathways Using Adenine Nucleotide Detection Assays
Tagged under: Transcreener AMP/GMP Assay, ubiquitin ligase assay

What you can read next

Unraveling RhoGDIα Regulation
Detecting Rho-GEF Activity Using the Transcreener® GDP Assay
High Throughput Screening Assays for Drug Discovery
High Throughput Screening Assays for Drug Discovery

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • PARG in Human Immunity

    Discovering the Emerging Importance of PARG in Immunity

    Poly (ADP-ribose) glycohydrolase (PARG), along ...
  • Helicases Used in Innate Immunity

    Helicases as Powerful Tools in Innate Immunity

    Helicases are among the largest and most highly...
  • Info book on cancer and RAFK1's relation

    RAF1 & Immunity: A Future Model For Cancer Research?

    RAF1, also known as c-Raf, is a member of the R...
  • OAS1 The Cost of Host Defense

    OAS1: The Cost of Host Defense

    OAS1 (Oligoadenylate synthetase 1) is induced b...
  • Scientist Studying DDX41

    DDX41 as a Sensor, Suppressor, and Modulator

    DDX41 [DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2022 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP